Heptadecanoic Acid 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl Ester

CAS : 1404053-62-8

Ref. TR-H281045

Informations sur le produit

• Nom: Heptadecanoic Acid 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl Ester
• Synonymes: Heptadecanoic acid, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl ester, 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl heptadecanoate, 9-Hydroxyrisperidone Heptadecanoate, Paliperidone Margarate, 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-9-yl Heptadecanoate

Description

Applications Heptadecanoic Acid 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl ester is a derivative of Paliperidone palmitate (P141020). Paliperidone palmitate is a long-acting injectable antipsychotic agent that is used to treat patients with schizophrenia.
References Hough, D., et al.: Prog. Neuro.-Psych. Biol. Psych., 33, 1022 (2009); Nasrallah, H., et al.: Neuropsychopharmacology, 35, 2072 (2010)

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 678.92
• Formule: C₄₀H₅₉FN₄O₄
• Couleur/Forme: White Solid
• InChI: InChI=1S/C40H59FN4O4/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19-37(46)48-35-18-17-25-45-39(35)42-30(2)33(40(45)47)24-28-44-26-22-31(23-27-44)38-34-21-20-32(41)29-36(34)49-43-38/h20-21,29,31,35H,3-19,22-28H2,1-2H3
• Code InChI: InChIKey=VDYWCSWBQPTHDB-UHFFFAOYSA-N
• SMILES: Cc1cnc2cc3nc(N)n(C)c3cc2n1